
|Videos|March 22, 2021
Dr. Eric Klein on genomic testing for genitourinary cancers
Author(s)Urology Times staff
“It’s really fascinating how the field is expanding,” Klein says.
Advertisement
“[Genomic testing is] going to be a routine part of prostate cancer care and urologic cancer care going forward,” Eric A. Klein, MD, says in this video. Klein is the Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Integration of doublet and triplet therapy in metastatic prostate cancer
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5






